We Can Help.

Contact us today for a complimentary consultation with a qualified attorney near you.

 
print page Bookmark and Share increase font size

Contact Us Today

Use this form to request a free consultation with a qualified attorney near you.

ATTORNEY ADVERTISING - Gacovino, Lake & Associates, P.C.
270 West Main Street
Sayville, NY 11782

Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.

Raptiva® (Efalizumab)

800-889-3898 

Generically known as efalizumab, Raptiva® is an injectable medication prescribed in the treatment of psoriasis, an autoimmune condition in which red, scaly plaques develop on the skin. Raptiva® works by suppressing the immune system and, thereby, minimizing the unsightly symptoms of psoriasis.

For most patients, Raptiva® doses are injected once a week in the thigh, upper arm, abdomen or buttocks. Doctors will develop an injection rotation plan that best suits an individual Raptiva® patient.

Severe Raptiva® Side Effects

Despite being effective at treating psoriasis, Raptiva® has been found to cause some serious, potentially fatal complications, including:

  • bacterial sepsis, a blood infection
  • invasive fungal disease
  • progressive multifocal leukoencephalopathy (PML), a viral infection that causes swelling in the brain's white matter
  • viral meningitis, an infection that results in inflammation in the brain and/or spinal cord.

Symptoms of these Raptiva® side effects may include:

  • black or blood stools
  • chills
  • confusion and/or disorientation
  • congestion
  • coughing
  • easy, unexplained bleeding, particularly from the gums and/or nose
  • fever
  • increased redness, pain or inflammation around skin wounds
  • painful or difficulty urinating

Raptiva® patients should seek emergency medical care, should they develop any combination of the above symptoms. Immediate treatment will be essential to saving injured patients' lives.

The FDA Issues Raptiva® Warnings

Due to the severity of Raptiva® side effects, the Food and Drug Administration (FDA) issued a nationwide Raptiva® warning on Oct. 16, 2008. In this alert, the FDA:

  • Warned the public about the life-threatening complications associated with Raptiva® drug use
  • Mandated that Genentech, the manufacturer of Raptiva®, include "black box" warnings on Raptiva® labels (Black box warnings are the most severe warning levels the FDA issues. They alert patients about the potential for death associated with using certain medications)

A comprehensive Raptiva® recall has yet to be issued.

Raptiva® Lawsuits

Patients injured after taking Raptiva® (or families of deceased Raptiva® patients) should set up an initial consultation with a personal injury lawyer once their health is stable.

During these meetings, prospective plaintiffs can:

  • Find out if they have a case against Genentech
  • Learn more about the process of building and winning Raptiva® lawsuits
  • Get an estimate of their possible settlement, based on prior settlements in cases similar to their own
  • Get advice about whether starting an individual case or joining a class-action lawsuit is best for their situation and needs

To encourage plaintiffs to seek out the compensation they deserve, Raptiva® lawyers offer these consultations for free and will delay payment for their services until a settlement is reached.

If You Have Been Injured by Raptiva®

Have you or a loved one been injured after taking Raptiva®? If so, contact us to speak with an experienced Raptiva® attorney who specializes in drug recall litigation & lawsuits. Let us help you win the compensation you need and deserve.

 

Contact a Raptiva Recall Lawyer